Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px

News > All

Total search results: 5466 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 48 49 50 ... 53 54 55  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Evotec AG. (7/24/17). "Press Release: Evotec and Bayer Advance Endometriosis Programme into Phase 1 Clinical Development and Extend Alliance". Hamburg. 2017-07-24
Definiens AG. (7/24/17). "Press Release: Definiens Forearms Organization for Strategic Expansion". Munich. 2017-07-24
Royal Philips. (7/24/17). "Press Release: Philips' Second Quarter Results 2017". 2017-07-24
Valneva S.E.. (7/24/17). "Press Release: Valneva Receives FDA Fast Track Designation for Its Lyme Disease Vaccine Candidate VLA15". Lyon. 2017-07-24
Bayer AG. (7/21/17). "Press Release: Phase II Trial of Investigational Anetumab Ravtansine Does Not Meet Primary Endpoint in Second-Line Mesothelioma [Not intended for U.S. and UK Media]". Berlin. 2017-07-21
Bayer AG. (7/21/17). "Press Release: Bayer’s Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation [...] [Not intended for U.S. and UK Media]". Berlin. 2017-07-21
Vifor Pharma AG. (7/21/17). "Press Release: European Commission Approves Marketing Authorisation for Veltassa". 2017-07-21
Oryzon Genomics S.A.. (7/20/17). "Press Release: Oryzon to Regain Rights to ORY-1001 (RG6016)". Barcelona & Cambridge, MA. 2017-07-20
Spindiag GmbH. (7/20/17). "Press Release: SpinDiag Raises 1.6 Mio EUR Seed-Capital to Bring Its Revolutionary Point-of-Care Screening System for Antibiotic Resistance to Initial Testing in Hospitals". Freiburg. 2017-07-20
CureVac AG. (7/20/17). "Press Release: CureVac to Receive Patent Claiming the Combination of mRNA Vaccines with Anti-PD-1 Antibodies". Tübingen. 2017-07-20
Philogen S.p.A.. (7/20/17). "Press Release: Philogen Enters into Multi-target Research Agreement with Boehringer Ingelheim in the Field of DNA-encoded Chemistry". Siena. 2017-07-20
Philips. (7/20/17). "Press Release: Chief Business Leader of Philips’ Personal Health Businesses Pieter Nota to Leave Company". Amsterdam. 2017-07-20
Ionicon Analytik GmbH. (7/20/17). "Press Release: Ionicon Launches AMC-Monitor T-1000 for the Semiconductor Industry". Innsbruck. 2017-07-20
Basilea Pharmaceutica Ltd.. (7/20/17). "Press Release: Basilea Announces Completion of the License Agreement with Pfizer for Antifungal Cresemba for Europe, Russia, Turkey and Israel". Basel. 2017-07-20
Sartorius AG. (7/19/17). "Press Release: Sartorius Supervisory Board Elects Dr. Lothar Kappich as Its Chairman". Göttingen. 2017-07-19
Novimmune S.A.. (7/18/17). "Press Release: Novimmune and Shire Sign License Agreement Deepening Bispecific Antibody Research Collaboration". Geneva. 2017-07-18
Agilent Technologies Inc.. (7/18/17). "Press Release: Hans E. Bishop to Join Agilent’s Board of Directors. CEO of Juno Therapeutics Brings Deep Knowledge of the Biopharma Industry". Santa Clara, CA. 2017-07-18
Royal Philips. (7/18/17). "Press Release: Philips to Strengthen Its Ultrasound Business with the Acquisition of Clinical Applications and Imaging Software Company TomTec". Amsterdam. 2017-07-18
Humabs BioMed S.A.. (7/18/17). "Press Release: Humabs BioMed and University of California, Berkeley Announce Publication of Data for Novel Antibody-based Assay to Detect Zika Virus Infection". Bellinzona & Berkeley, CA. 2017-07-18
4SC AG. (7/18/17). "Press Release: 4SC Licenses Kv1.3 Inhibitors to Maruho. Maruho to Receive Exclusive Worldwide License on 4SC’s Preclinical Inhibitors of the Kv1.3 Ion Channel". Planegg-Martinsried. 2017-07-18
Novartis AG. (7/18/17). "Press Release: Q2 Results Confirm Full Year Guidance". Basel. 2017-07-18
Eurofins Scientific. (7/18/17). "Press Release: Eurofins Issues EUR 650m New Euro Bond". 2017-07-18
Autolus Therapeutics Ltd.. (7/18/17). "Press Release: Autolus Announces Senior Leadership Appointments". London. 2017-07-18
BASF SE. (7/17/17). "Press Release: BASF and Kaiima Announce Collaboration to Identify Novel Herbicide Resistance Traits Using the EP Technology Platform". Limburgerhof & Moshav Sharona. 2017-07-17
Eurofins Scientific. (7/17/17). "Press Release: Eurofins Announces the Potential Launch of a New Senior EUR 500m Bond on the Back of Strong M&A Activity". 2017-07-17
VeroVaccines GmbH. (7/17/17). "Press Release: VeroVaccines GmbH Founded in Halle (Saale), Germany". 2017-07-17
Novartis AG. (7/14/17). "Press Release: Novartis Confirms 5 Year Data for First and Only Fully-human IL-17A Inhibitor Cosentyx Reinforcing Sustained Efficacy and Safety Profile in Psoriasis". Basel. 2017-07-14
PreOmics GmbH. (7/14/17). "Press Release: Diagenode and PreOmics Launch New Streamlined Sample Preparation Solution for Proteomic Analyses". Liège, Denville & Martinsried. 2017-07-14
Novartis AG. (7/13/17). "Press Release: Novartis CAR-T Cell Therapy CTL019 Unanimously (10-0) Recommended for Approval by FDA Advisory Committee to Treat Pediatric, Young Adult r/r B-cell ALL". Basel. 2017-07-13
MorphoSys AG. (7/13/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received US FDA Approval for Tremfya (Guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis". Planegg-Martinsried. 2017-07-13
BASF SE. (7/13/17). "Press Release: BASF Introduces First New Class of Public Health Insecticide for Malaria Prevention in more than 30 Years". Limburgerhof. 2017-07-13
Wilex AG. (7/13/17). "Press Release: Wilex Reports on First Half-year". Munich. 2017-07-13
Johnson & Johnson Inc.. (7/13/17). "Press Release: Janssen Announces U.S. FDA Approval of Tremfya (guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis". Horsham, PA. 2017-07-13
Epigenomics AG. (7/12/17). "Press Release: Epigenomics AG – Voluntary Public Takeover Offer by Summit Hero Holding Not Successful". Berlin. 2017-07-12
Merck KGaA. (7/12/17). "Press Relase: Merck Refines Western European Life Science Production Site Network". Darmstadt. 2017-07-12
Creathor Venture Management GmbH. (7/11/17). "Press Release: Creathor Venture Invests in AI-enabled Clinical Genetic Testing Company Blueprint Genetics as Part of an up to EUR 14 Million Financing Round". Bad Homburg v. d. H.. 2017-07-11
Numares AG. (7/11/17). "Press Release: Numares AG Achieves Key Milestone – Identifies Candidate Metabolomic Network for Bladder Cancer Diagnostics". Regensburg. 2017-07-11
Genedata AG. (7/11/17). "Press Release: Genedata Selector Expands Partnership with AB Enzymes". Basel. 2017-07-11
Enterome S.A.. (7/11/17). "Press Release: Enterome and Nestlé Health Sciences Launch New Diagnostics Company". Paris. 2017-07-11
Noxxon Pharma N.V.. (7/11/17). "Press Release: Noxxon Pharma Announces Prospectus Publication and Share Transfer to the Public Offering Compartment of the EuroNext Growth Market". Berlin. 2017-07-11
Silence Therapeutics plc. (7/10/17). "Press Release: IP Update". 2017-07-10
CRISPR Therapeutics AG. (7/10/17). "Press Release: CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration". Cambridge, MA & Basel. 2017-07-10
Phenex Pharmaceuticals AG. (7/10/17). "Press Release: Phenex AG Announces Milestone Payment from Janssen for the Entry of RORgt Inhibitor into Phase I". Ludwigshafen. 2017-07-10
Stada Arzneimittel AG. (7/10/17). "Press Release: Stada Supports Renewed Improved Takeover Offer Announced by Bain Capital and Cinven". Bad Vilbel. 2017-07-10
Curetis N.V.. (7/7/17). "Press Release: Curetis to Attend Key Investor and Scientific Conferences in the Third Quarter 2017". Amsterdam & Holzgerlingen. 2017-07-07
Evotec AG. (7/6/17). "Press Release: Evotec Received Funding from IFB Hamburg to Identify Antibody-mediated T-Cell Immunotherapies". Hamburg. 2017-07-06
Epigenomics AG. (7/6/17). "Press Release: Epigenomics AG Issues Change in Guidance for Financial Year 2017". 2017-07-06
4SC AG. (7/6/17). "Press Release: 4SC AG Secures EUR 41 Million from Successful Capital Increase [Not for US, AU, CA, JP or ZA]". Planegg-Martinsried. 2017-07-06
Evolva Holding S.A.. (7/6/17). "Press Release: Neil Goldsmith Stepping Down as CEO and Board Member of Evolva". 2017-07-06
Oxford Biomedica plc. (7/6/17). "Press Release: Oxford BioMedica Announces a Major Supply Agreement". Oxford. 2017-07-06
Lonza Group Ltd.. (7/6/17). "Press Release: Lonza Completes Acquisition of Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries". Basel. 2017-07-06
CRISPR Therapeutics AG. (7/5/17). "Press Release: CRISPR Therapeutics to Present at the Piper Jaffray GenomeRx Symposium". Basel & Cambridge, MA. 2017-07-05
Horizon Discovery Group plc. (7/5/17). "Press Release: Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform". Cambridge. 2017-07-05
Seventure Partners. (7/5/17). "Press Release: Health for Life Capital Participates in $13.2m Financing of Japanese Microbiome Leader Anaeropharma Science". Paris. 2017-07-05
Roche Diagnostics GmbH. (7/5/17). "Pressemitteilung: Roche weiht Neubauten des Biotechnologie-Zentrums in Penzberg ein. Investitionen am Roche Standort Penzberg von 600 Millionen Euro". Penzberg. 2017-07-05
Eurofins Scientific. (7/4/17). "Press Release: Eurofins Announces AOAC and AFNOR Certification for BACGene and BACSpec Listeria Kits". 2017-07-04
Noxxon Pharma N.V.. (7/4/17). "Press Release: Noxxon Announces First Patients Treated in Phase I/II Clinical Trial of NOX-A12 Combined with Keytruda in Metastatic Pancreatic and Colorectal Cancer". Berlin. 2017-07-04
Zealand Pharma A/S. (7/3/17). "Press Release: Zealand Initiates First Phase 3 Trial with Dasiglucagon for the Treatment of Severe Hypoglycemia in Diabetes". Copenhagen. 2017-07-03
Silence Therapeutics plc. (7/3/17). "Press Release: Change of Adviser". 2017-07-03
Silence Therapeutics plc. (7/3/17). "Press Release: Issue of Claim in the UK High Courts". 2017-07-03
Analytik Jena AG. (6/30/17). "Press Release: Analytik Jena Sells AJ Blomesystem". Jena & Cologne. 2017-06-30
Oxford Biomedica plc. (6/30/17). "Press Release: Oxford BioMedica Announces Refinancing of Debt Facility". London. 2017-06-30
mySugr GmbH. (6/30/17). "Press Release: mySugr Joins the Roche family". San Diego, CA. 2017-06-30
iTeos Therapeutics S.A.. (6/29/17). "Press Release: iTeos Therapeutics Appoints Mohamed Ragab, M.D., as Vice President, Corporate Development". Gosselies. 2017-06-29
Arbeitskreis der BioRegionen. (6/28/17). "Press Release: Dr. Hinrich Habeck folgt nach sechs Jahren Dr. Klaus Eichenberg in seinem Amt. Der neue Sprecher des AK BioRegio setzt auf Fortführung des Erfolgskurses". Berlin. 2017-06-28
Evotec AG. (6/28/17). "Press Release: Evotec Expands iPSC Drug Discovery Leadership through Strategic Collaboration with Censo Biotechnologies". Hamburg. 2017-06-28
Cellnovo. (6/28/17). "Press Release: Cellnovo Signs Expanded Agreement to Build Second Production Line with Flex". Paris. 2017-06-28
Cellectis S.A.. (6/28/17). "Press Release: Cellectis Appoints Rainer Boehm, M.D. and Hervé Hoppenot to Board of Directors". New York, NY. 2017-06-28
Indi Molecular. (6/28/17). "Press Release: Indi Molecular Raises $11.5M Series A to Accelerate PCC Platform Development". Culver City, CA. 2017-06-28
BioGeneration Ventures B.V.. (6/27/17). "Press Release: BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target". Naarden. 2017-06-27
Selexis S.A.. (6/27/17). "Press Release: Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins". Geneva. 2017-06-27
Miltenyi Biotec GmbH. (6/27/17). "Press Release: Miltenyi Biotec Acquires Sensovation". 2017-06-27
Oculis ehf.. (6/27/17). "Press Release: Eye-drop for Diabetic Retinopathy – Successful Eurostars grant Application". Reykjavik. 2017-06-27
Bruker Corporation. (6/26/17). "Press Release: Bruker Announces Novel NMR Phenomics Research Capabilities". Brisbane. 2017-06-26
CureVac AG. (6/26/17). "Press Release: CureVac Expands GMP Production Capacities for RNA Products". Tübingen. 2017-06-26
EQT Partners. (6/24/17). "Press Release: EQT VII to Invest in Global »Hidden Champion« and Medical Mobility Technology Market Leader Ottobock". 2017-06-24
Tecan Group Ltd.. (6/23/17). "Press Release: DiaSorin and Tecan to Collaborate in New Platform Development". Saluggia & Männedorf. 2017-06-23
Merck KGaA. (6/23/17). "Press Release: Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis". Darmstadt. 2017-06-23
NMI TT Pharmaservices. (6/22/17). "Press Release: NMI TT Pharmaservices and Charité Awarded Grant for Development of Protein Profiling for Individualization of Tumor Therapy". Berlin. 2017-06-22
DiaSorin S.p.A.. (6/22/17). "Press Release: DiaSorin and Qiagen Sign Collaboration to Expand Liaison Test Menu througth Adoption of Select Qiagen Assays". Saluggia, Hilden & Germantown, MD. 2017-06-22
Evotec AG. (6/22/17). "Press Release: »Lab282« Accelerates with Second Round Funding". Hamburg. 2017-06-22
Thermo Fisher Scientific Inc.. (6/22/17). "Press Release: FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies". Carlsbad, CA. 2017-06-22
Waters Corporation. (6/22/17). "Press Release: Waters Corporation Elects Flemming Ornskov to Board of Directors". Milford, MA. 2017-06-22
Repare Therapeutics Inc.. (6/22/17). "Press Release: Repare Therapeutics Raises US$68 Million Series A. Novel Cancer Company Founded by Versant Ventures". 2017-06-22
Boehringer Ingelheim. (6/21/17). "Press Release: New Data Reveal High Rates of Stroke History in Asymptomatic Atrial Fibrillation Patients". Ingelheim. 2017-06-21
Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf. 2017-06-21
InflaRx GmbH. (6/21/17). "Press Release: InflaRx Promotes Othmar Zenker, M.D. to Newly Created Position of Chief Medical Officer". Jena. 2017-06-21
Shimadzu Europe GmbH. (6/21/17). "Press Release: Shimadzu Has Acquired AlsaChim, a Specialist for High-quality Analytical Isotope Labeled Standards". 2017-06-21
OBN (UK) Ltd.. (6/20/17). "Press Release: OBN (UK) and Eurasanté (FR) Announce the Launch of BioSeed. A New European Equity Investment Event to Support Early-Stage Companies in Life Sciences". Oxford. 2017-06-20
Merck KGaA. (6/20/17). "Press Release: Merck Ventures Creates New Immuno-Oncology Company iOnctura". Darmstadt. 2017-06-20
Evotec AG. (6/20/17). "Press Release: Evotec Announces Strategic Investment in Facio Therapies to Support Development of Novel FSHD Therapy". Hamburg. 2017-06-20
Affiris AG. (6/20/17). "Press Release: Vaccine that Lowers Cholesterol in Mice Offers Hope of Immunising against Cardiovascular Disease". 2017-06-20
Debiopharm International SA. (6/20/17). "Press Release: Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor". Craigavon & Lausanne. 2017-06-20
PerkinElmer, Inc.. (6/19/17). "Press Release: PerkinElmer to Acquire Euroimmun for Approximately $1.3 Billion". Waltham, MA. 2017-06-19
CRISPR Therapeutics AG. (6/19/17). "Press Release: CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China". Basel. 2017-06-19
Gamida Cell Ltd.. (6/19/17). "Press Release: Gamida Cell Announces $40 Million Private Financing". Jerusalem. 2017-06-19
Intellia Therapeutics, Inc.. (6/19/17). "Press Release: Intellia Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China". Cambridge, MA. 2017-06-19
TxCell S.A.. (6/19/17). "Press Release: TxCell Appoints Lentigen Technology, Inc. to Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection". Valbonne. 2017-06-19
Wilex AG. (6/19/17). "Press Release: Wilex Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates". Munich. 2017-06-19
Novartis AG. (6/19/17). "Press Release: Sandoz Receives Approval in Europe for Rixathon (Biosimilar Rituximab) to Treat Blood Cancers and Immunological Diseases". Holzkirchen. 2017-06-19
next pagenext page 1 2 3 ... 48 49 50 ... 53 54 55  next pagenext page


Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group World of Partnering Opportunities 650x300px

» top